Heart Rate Recovery, Physical Activity Level, and Functional Status in Subjects With COPD

References

1. 1.↵
   1. Shiroishi R,
   2. Kitagawa C,
   3. Miyamoto N,
   4. Kakuno N,
   5. Koyanagi H,
   6. Rikitomi N,
   7. Seniyu H

   . Heart rate recovery after the 6-min walk test is related to 6-min walk distance and percutaneous oxygen saturation recovery in patients with COPD. Respirology 2015;20(4):671–673.

   OpenUrl
2. 2.↵
   1. Gupta M,
   2. Bansal V,
   3. Chhabra SK

   . Abnormal heart rate recovery and chronotropic incompetence on exercise in chronic obstructive pulmonary disease. Chron Respir Dis 2013;10(3):117–126.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Lacasse M,
   2. Maltais F,
   3. Poirier P,
   4. Lacasse Y,
   5. Marquis K,
   6. Jobin J,
   7. LeBlanc P

   . Post-exercise heart rate recovery and mortality in chronic obstructive pulmonary disease. Respir Med 2005;99(7):877–886.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Rodríguez DA,
   2. Kortianou EA,
   3. Alison JA,
   4. Casas A,
   5. Giavedoni S,
   6. Barberan-Garcia A,
   7. et al

   . Heart rate recovery after 6-min walking test predicts acute exacerbation in COPD. Lung 2017;195(4):463–467.

   OpenUrl
5. 5.↵
   1. Holland AE,
   2. Spruit MA,
   3. Troosters T,
   4. Puhan MA,
   5. Pepin V,
   6. Saey D,
   7. et al

   . An official European Respiratory Society/American Thoracic Society technical standard: Field walking tests in chronic respiratory disease. Eur Respir J 2014;44(6):1428–1446.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Hernandes NA,
   2. Wouters EF,
   3. Meijer K,
   4. Annegarn J,
   5. Pitta F,
   6. Spruit MA

   . Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J 2011;38(2):261–267.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Pitta F,
   2. Troosters T,
   3. Spruit MA,
   4. Probst VS,
   5. Decramer M,
   6. Gosselink R

   . Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171(9):972–977.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Hernandes NA,
   2. Teixeira DC,
   3. Probst VS,
   4. Brunetto AF,
   5. Ramos EM,
   6. Pitta F

   . Profile of the level of physical activity in the daily lives of patients with COPD in Brazil. J Bras Pneumol 2009;35(10):949–956.

   OpenUrlPubMed
9. 9.↵
   1. Pitta F,
   2. Troosters T,
   3. Probst VS,
   4. Spruit MA,
   5. Decramer M,
   6. Gosselink R

   . Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 2006;27(5):1040–1055.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Waschki B,
    2. Kirsten A,
    3. Holz O,
    4. Müller KC,
    5. Meyer T,
    6. Watz H,
    7. Magnussen H

    . Physical activity is the strongest predictor of all-cause mortality in patients with COPD: A prospective cohort study. Chest 2011;140(2):331–342.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Probst VS,
    2. Kovelis D,
    3. Hernandes NA,
    4. Camillo CA,
    5. Cavalheri V,
    6. Pitta F

    . Effects of 2 exercise training programs on physical activity in daily life in patients with COPD. Respir Care 2011;56(11):1799–1807.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Vestbo J,
    2. Hurd SS,
    3. Agustí AG,
    4. Jones PW,
    5. Volgelmeier C,
    6. Anzueto A,
    7. et al

    . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347–365.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Britto RR,
    2. Probst VS,
    3. de Andrade AF,
    4. Samora GA,
    5. Hernandes NA,
    6. Marinho PE,
    7. et al

    . Reference equations for the six-minute walk distance based on a Brazilian multicenter study. Braz J Phys Ther 2013;17(6):556–563.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Pereira CA,
    2. Sato T,
    3. Rodrigues SC

    . New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 2007;33(4):397–406.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Van Remoortel H,
    2. Giavedoni S,
    3. Raste Y,
    4. Burtin C,
    5. Louvaris Z,
    6. Gimeno-Santos E,
    7. et al

    . Validity of activity monitors in health and chronic disease: A systematic review. Int J Behav Nutr Phys Act 2012;9:84.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Rabinovich RA,
    2. Louvaris Z,
    3. Raste Y,
    4. Langer D,
    5. Van Remoortel H,
    6. Giavedoni S,
    7. et al

    . Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 2013;42(5):1205–1215.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Demeyer H,
    2. Burtin C,
    3. Van Remoortel H,
    4. Hornikx M,
    5. Langer D,
    6. Decramer M,
    7. et al

    . Standardizing the analysis of physical activity in patients with COPD following a pulmonary rehabilitation program. Chest 2014;146(2):318–327.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Kovelis D,
    2. Segretti NO,
    3. Probst VS,
    4. Lareau SC,
    5. Brunetto AF,
    6. Pitta F

    . Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol 2008;34(12):1008–1018.

    OpenUrlPubMed
20. 20.↵
    1. Camelier A,
    2. Rosa FW,
    3. Salim C,
    4. Nascimento OA,
    5. Cardoso F,
    6. Jardim JR

    . Using the Saint George's Respiratory Questionnaire to evaluate quality of life in patients with chronic obstructive pulmonary disease: Validating a new version for use in Brazil. J Bras Pneumol 2006;32(2):114–122.

    OpenUrlPubMed
21. 21.↵
    1. Pitta F,
    2. Probst VS,
    3. Kovelis D,
    4. Segretti NO,
    5. Mt Leoni A,
    6. Garrod R,
    7. Brunetto AF

    . Validation of the Portuguese version of the London Chest Activity of Daily Living Scale (LCADL) in chronic obstructive pulmonary disease patients. Rev Port Pneumol 2008;14(1):27–47.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Furlanetto KC,
    2. Donária L,
    3. Schneider LP,
    4. Lopes JR,
    5. Ribeiro M,
    6. Fernandes KB,
    7. et al

    . Sedentary behavior is an independent predictor of mortality in Subjects with COPD. Respir Care 2017;62(5):579–587.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Cole CR,
    2. Blackstone EH,
    3. Pashkow FJ,
    4. Snader CE,
    5. Lauer MS

    . Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999;341(18):1351–1357.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Seshadri N,
    2. Gildea TR,
    3. Mccarthy K,
    4. Pothier C,
    5. Kavuru MS,
    6. Lauer MS

    . Association of an abnormal exercise heart rate recovery with pulmonary function abnormalities. Chest 2004;125(4):1286–1291.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Camillo CA,
    2. Pitta F,
    3. Possani HV,
    4. Barbosa MV,
    5. Marques DS,
    6. Cavalheri V,
    7. et al

    . Heart rate variability and disease characteristics in patients with COPD. Lung 2008;186(6):393–401.

    OpenUrlPubMed
26. 26.↵
    1. Thirapatarapong W,
    2. Armstrong HF,
    3. Bartels MN

    . Exercise capacity and ventilatory response during exercise in COPD patients with and without β blockade. Lung 2013;191(5):531–536.

    OpenUrlCrossRefPubMed